CHI's Emerging Diagnostic Partnering & Investment Partnering Forum

The pace of innovation, both technically and in terms of commercialization strategies, continues to accelerate within the field of molecular diagnostics, making the right strategic partnerships critical to the development of promising new technologies and applications. CHI’s Emerging Diagnostic Partnering & Investment Forum will bring together exciting early stage companies with decision makers representing pharma, larger biotechs, and VCs, providing an efficient opportunity to learn about emerging technologies and engage in networking, partnering and investment exploration discussions.